Frequency of Ovarian Malignancy in Patients with a High-Risk Malignancy Index
Horizon · 15.04.2026 · 1 (2) · 13
DOI: 10.66547/481920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Horizon, online erschienen am 15.04.2026. Verfasst von Maria Soomro und 4 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To ascertain the frequency of ovarian malignancy in women presenting with a high Risk of Malignancy Index (RMI) score in pre-operative, clinically suspected adnexal masses.
Methods
This prospective study was conducted at the Dept. of OBGYN at Liaquat University Hospital, Hyderabad/Jamshoro, over six months after institutional ethical approval. A total of 253 women scheduled for surgical intervention for clinically suspected adnexal masses were enrolled by consecutive sampling. The preoperative RMI was calculated as the product of the ultrasound score, menopausal-status score, and serum CA-125. An RMI > 250 defined high risk. Postoperative histopathology served as the diagnostic gold standard. Data were analysed using SPSS version 22.0; Chi-square testing was applied with p < 0.05 considered significant.
Results
The mean age of the cohort was 42.69 ± 12.48 years. Histopathology revealed that 96.8% (245/253) of masses were benign and 3.2% (8/253) were malignant. Among patients with a high-risk RMI score (> 250), 2.8% (7/253) had an ovarian malignancy, compared with 0.4% (1/253) of patients with an RMI ≤ 250. The association between high RMI score and ovarian malignancy was statistically significant (p = 0.047). High RMI scores also showed significant associations with the 36–50 years age category (p = 0.001) and parity of 1–3 (p = 0.001).
Conclusion
An RMI score > 250 is significantly predictive of ovarian malignancy and provides a reliable, practical tool for preoperative risk stratification, helping avoid unnecessary aggressive surgery for benign lesions and ensuring timely referral of high-risk patients to gynaecologic oncology centres.
Zitieren
APA
Soomro, M., Parveen, N., Channa, S. R., Erum, Z., & Memon, A. (2026). Frequency of Ovarian Malignancy in Patients with a High-Risk Malignancy Index. Horizon, 1(2), 13. https://doi.org/10.66547/481920
Vancouver
Soomro M, Parveen N, Channa SR, Erum Z, Memon A. Frequency of Ovarian Malignancy in Patients with a High-Risk Malignancy Index. Horizon. 2026;1(2):13. doi:10.66547/481920
BibTeX
@article{Soomro2026,
author = {Soomro, Maria and Parveen, Naheed and Channa, Shehla Raza and Erum, Zarka and Memon, Aqsa},
title = {Frequency of Ovarian Malignancy in Patients with a High-Risk Malignancy Index},
journal = {Horizon},
year = {2026},
volume = {1},
number = {2},
pages = {13},
doi = {10.66547/481920}
}
EUVIMED